Close Menu

The Scan

A new UK government says socioeconomic factors, not genetics, account for disparities in deaths due to COVID-19 between ethnic groups, the Financial Times reports.

NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.

In Nature this week: CRISPR-Cas3 system for making large deletions efficiently, more.

The New York Times reports on how the US Food and Drug Administration has attempted to gird against pressure from the White House.

Independent advisors to the US Food and Drug Administration are to meet this week to discuss how they will make SARS-CoV-2 vaccine recommendations, the Washington Post reports.

Gene for When to Go

Researchers have identified a gene involved in how people determine when to urinate.

In Genome Research this week: assay for profiling chromatin accessibility, analysis of genetic variants among malaria-transmitting mosquitoes, and more.

Watching the Changes

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.

CMS Letter to Orig3n

Bloomberg reports the US Centers for Medicare & Medicaid Services sent Orig3n a letter saying it has not corrected lab issues uncovered in an earlier inspection.

And After the Test

In an editorial at BMJ Opinion, two genetic counselors call for an increased focus on post-test patient care.

A new survey finds people in the US are getting their COVID-19 test results back faster, but not fast enough to help some viral control measures, NPR reports.

In PLOS this week: genomic analysis of malaria parasites in Ethiopia, loci linked to childhood BMI, and more.

New Scientist reports that a new genetic analysis suggests some saber-toothed cats may have lived in packs and been fast runners.

Almost As Good

A small study has found that a rapid test for SARS-CoV-2 works about as well as a PCR test, according to the New York Times.

New OA Model

PLOS is piloting a new model under which research institutions pay a flat fee for its researchers to publish in its journals, Science reports.

In Science this week: honey bees recognize colony mates by their gut microbiomes, and more.

Back in 5

Reuters reports University of Oxford researchers have developed a test for SARS-CoV-2 that can return results in five minutes.

Suit Over Pay

Five tenured Rutgers University professors are suing the school over pay disparities, according to the New York Times

"Dangerous" Proposal

The Washington Post reports that a herd immunity proposal has found a receptive audience at the White House to the dismay of most scientists.

In Nature this week: Akita method to predict genome folding based DNA sequence data, and more.

The Wall Street Journal reports clinical labs are grappling with staffing shortages, an issue exacerbated by the pandemic.

Researchers have linked three common gene variants to severe COVID-19 risk, Science reports.

Pages

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.